DHRS7C
gene geneOn this page
Also known as SDR32C2
Summary
DHRS7C (dehydrogenase/reductase 7C, HGNC:32423) is a protein-coding gene on chromosome 17p13.1, encoding Dehydrogenase/reductase SDR family member 7C (A6NNS2). NADH-dependent oxidoreductase which catalyzes the oxidation of all-trans-retinol to all-trans-retinal.
Predicted to enable all-trans-retinol dehydrogenase (NAD+) activity. Predicted to be involved in D-glucose import; intracellular calcium ion homeostasis; and regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum. Predicted to be located in longitudinal sarcoplasmic reticulum and sarcoplasmic reticulum membrane.
Source: NCBI Gene 201140 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 50 total
- MANE Select transcript:
NM_001105571
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32423 |
| Approved symbol | DHRS7C |
| Name | dehydrogenase/reductase 7C |
| Location | 17p13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SDR32C2 |
| Ensembl gene | ENSG00000184544 |
| Ensembl biotype | protein_coding |
| OMIM | 616161 |
| Entrez | 201140 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000330255, ENST00000571134, ENST00000571771
RefSeq mRNA: 2 — MANE Select: NM_001105571
NM_001105571, NM_001220493
CCDS: CCDS56020, CCDS58517
Canonical transcript exons
ENST00000571134 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001299396 | 9772767 | 9772922 |
| ENSE00001309783 | 9771438 | 9771696 |
| ENSE00001316112 | 9777193 | 9777285 |
| ENSE00001320148 | 9781482 | 9781594 |
| ENSE00002681802 | 9779825 | 9780035 |
| ENSE00003907828 | 9791131 | 9791592 |
Expression profiles
Bgee: expression breadth ubiquitous, 125 present calls, max score 97.83.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3330 / max 82.3654, expressed in 39 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 164498 | 0.3330 | 39 |
Top tissues by expression
231 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| vastus lateralis | UBERON:0001379 | 97.83 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 97.62 | gold quality |
| biceps brachii | UBERON:0001507 | 97.41 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 97.30 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 97.21 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 96.88 | gold quality |
| quadriceps femoris | UBERON:0001377 | 96.86 | gold quality |
| right atrium auricular region | UBERON:0006631 | 96.53 | gold quality |
| cardiac atrium | UBERON:0002081 | 96.24 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 95.48 | gold quality |
| gastrocnemius | UBERON:0001388 | 93.50 | gold quality |
| apex of heart | UBERON:0002098 | 93.27 | gold quality |
| myocardium | UBERON:0002349 | 92.52 | gold quality |
| muscle of leg | UBERON:0001383 | 91.97 | gold quality |
| deltoid | UBERON:0001476 | 91.14 | gold quality |
| muscle tissue | UBERON:0002385 | 90.99 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 90.21 | gold quality |
| tibialis anterior | UBERON:0001385 | 87.15 | silver quality |
| body of tongue | UBERON:0011876 | 86.64 | gold quality |
| heart left ventricle | UBERON:0002084 | 85.41 | gold quality |
| cardiac ventricle | UBERON:0002082 | 85.11 | gold quality |
| heart | UBERON:0000948 | 82.63 | gold quality |
| heart right ventricle | UBERON:0002080 | 82.31 | gold quality |
| tongue | UBERON:0001723 | 77.41 | gold quality |
| vena cava | UBERON:0004087 | 77.30 | gold quality |
| kidney epithelium | UBERON:0004819 | 69.64 | gold quality |
| superior surface of tongue | UBERON:0007371 | 67.40 | gold quality |
| gingival epithelium | UBERON:0001949 | 66.31 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 65.67 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 63.15 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.46 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- The expression of DHRS7c, a novel endo/sarcoplasmic reticulum-localized a short chain dehydrogenase/reductase, is inversely correlated with adrenergic stimulation and heart failure development. (PMID:22143674)
Cross-species orthologs
16 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dhrs7ca | ENSDARG00000039453 |
| danio_rerio | dhrs7cb | ENSDARG00000071877 |
| mus_musculus | Dhrs7c | ENSMUSG00000033044 |
| rattus_norvegicus | Dhrs7c | ENSRNOG00000026548 |
| drosophila_melanogaster | CG7601 | FBGN0027583 |
| drosophila_melanogaster | CG31546 | FBGN0051546 |
| drosophila_melanogaster | CG31548 | FBGN0051548 |
| caenorhabditis_elegans | WBGENE00000970 | |
| caenorhabditis_elegans | WBGENE00000975 | |
| caenorhabditis_elegans | WBGENE00000981 | |
| caenorhabditis_elegans | WBGENE00000993 | |
| caenorhabditis_elegans | WBGENE00008985 | |
| caenorhabditis_elegans | WBGENE00008986 | |
| caenorhabditis_elegans | WBGENE00011424 | |
| caenorhabditis_elegans | WBGENE00022809 | |
| caenorhabditis_elegans | WBGENE00219274 |
Paralogs (13): RDH8 (ENSG00000080511), DHRS7 (ENSG00000100612), DHRS2 (ENSG00000100867), DHRS7B (ENSG00000109016), HSD11B1 (ENSG00000117594), HSDL2 (ENSG00000119471), DHRS4 (ENSG00000157326), DHRS1 (ENSG00000157379), CBR1 (ENSG00000159228), CBR3 (ENSG00000159231), HSD11B1L (ENSG00000167733), DHRS4L2 (ENSG00000187630), DHRS11 (ENSG00000278535)
Protein
Protein identifiers
Dehydrogenase/reductase SDR family member 7C — A6NNS2 (reviewed: A6NNS2)
Alternative names: Sarcoplasmic reticulum protein of 35 kDa, Short-chain dehydrogenase/reductase family 32C member 2
All UniProt accessions (2): A6NNS2, I3NI52
UniProt curated annotations — full annotation on UniProt →
Function. NADH-dependent oxidoreductase which catalyzes the oxidation of all-trans-retinol to all-trans-retinal. Plays a role in the regulation of cardiac and skeletal muscle metabolic functions. Maintains Ca(2+) intracellular homeostasis by repressing Ca(2+) release from the sarcoplasmic reticulum (SR) in myotubes, possibly through local alternations in NAD/NADH or retinol/retinal. Also plays a role in Ca(2+) homeostasis by controlling Ca(2+) overload in the cytosol and the SR in myotubes. Involved in glucose uptake into skeletal muscles and muscle performance by activating PI3K and mTORC2-mediated AKT1 phosphorylation signaling pathways, possibly through the action of its downstream catalytic product all-trans-retinoic acid.
Subcellular location. Sarcoplasmic reticulum membrane.
Domain organisation. The N-terminus region encompasses a short hydrophobic sequence bound to the sarcoplasmic reticulum membrane, whereas the C-terminus catalytic domain faces the myoplasm.
Similarity. Belongs to the short-chain dehydrogenases/reductases (SDR) family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A6NNS2-1 | 1 | yes |
| A6NNS2-2 | 2 |
RefSeq proteins (2): NP_001099041, NP_001207422 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002347 | SDR_fam | Family |
| IPR020904 | Sc_DH/Rdtase_CS | Conserved_site |
| IPR036291 | NAD(P)-bd_dom_sf | Homologous_superfamily |
| IPR052148 | SDR_family_member_7C | Family |
Pfam: PF00106
Catalyzed reactions (Rhea), 1 shown:
- all-trans-retinol + NAD(+) = all-trans-retinal + NADH + H(+) (RHEA:21284)
UniProt features (10 total): binding site 5, signal peptide 1, chain 1, active site 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NNS2-F1 | 87.11 | 0.67 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 192 (proton acceptor)
Ligand- & substrate-binding residues (5): 47; 49; 192; 196; 227
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (3): intracellular calcium ion homeostasis (GO:0006874), regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880), obsolete D-glucose import (GO:0046323)
GO Molecular Function (3): all-trans-retinol dehydrogenase (NAD+) activity (GO:0004745), oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616), oxidoreductase activity (GO:0016491)
GO Cellular Component (5): longitudinal sarcoplasmic reticulum (GO:0014801), sarcoplasmic reticulum membrane (GO:0033017), cytoplasm (GO:0005737), membrane (GO:0016020), sarcoplasmic reticulum (GO:0016529)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| sarcoplasmic reticulum | 2 |
| intracellular monoatomic cation homeostasis | 1 |
| calcium ion homeostasis | 1 |
| release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1 |
| regulation of release of sequestered calcium ion into cytosol | 1 |
| alcohol dehydrogenase (NAD+) activity | 1 |
| oxidoreductase activity, acting on CH-OH group of donors | 1 |
| catalytic activity | 1 |
| endoplasmic reticulum membrane | 1 |
| bounding membrane of organelle | 1 |
| intracellular anatomical structure | 1 |
| endoplasmic reticulum | 1 |
| sarcoplasm | 1 |
Protein interactions and networks
STRING
2973 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DHRS7C | SAYSD1 | Q9NPB0 | 649 |
| DHRS7C | AKIP1 | Q9NQ31 | 607 |
| DHRS7C | MCRIP1 | C9JLW8 | 607 |
| DHRS7C | DNAH8 | Q96JB1 | 497 |
| DHRS7C | RCVRN | P35243 | 434 |
| DHRS7C | VSTM5 | A8MXK1 | 420 |
| DHRS7C | GCKR | Q14397 | 383 |
| DHRS7C | GLP2R | O95838 | 379 |
| DHRS7C | DPP4 | P27487 | 374 |
| DHRS7C | GIPR | P48546 | 369 |
| DHRS7C | PRL | P01236 | 350 |
| DHRS7C | DNAH5 | Q8TE73 | 349 |
| DHRS7C | TLCD1 | Q96CP7 | 341 |
| DHRS7C | GCG | P01275 | 336 |
| DHRS7C | STX8 | Q9UNK0 | 332 |
IntAct
0 interactions, top by confidence:
BioGRID (2): DHRS7C (Synthetic Lethality), DHRS7C (Affinity Capture-MS)
ESM2 similar proteins: A1YER2, A1YFX9, A2T7G9, A6NNS2, B0BN93, B0BNF8, O22718, O35331, O35678, O75911, O77769, O80526, O88876, O95154, P11172, P14755, P15904, P84169, Q06136, Q15738, Q1RMJ5, Q28DS0, Q2KIJ5, Q2QNG7, Q2QZ86, Q3SZM9, Q3T067, Q3ZBE9, Q5E964, Q5I0K3, Q5PPL3, Q5R514, Q5R5C9, Q5RDZ2, Q6AY30, Q6UWP2, Q811X6, Q86WA6, Q8JGT5, Q8K183
Diamond homologs: A0A017SEY2, A0A078ISJ6, A0A0C6DRT7, A0A0U5CNP2, A0A140FAN3, A0A1B7YCL6, A0A1J0HSL5, A0A1U8QWA2, A0A1V0QS34, A0A2H3CZZ2, A0A2H3D905, A0A4P8W851, A0PJE2, A2RVM0, A6NNS2, A7AZH2, B2X050, D3ZGP9, D7UQ42, D7UTD0, E3VWI6, G9FRD7, I1RL15, K2RU68, M2ZIX7, O05730, O06413, O32229, O74959, O86034, P0DKC7, P16152, P16542, P23102, P35320, P41177, P47727, P50199, P50200, P50203
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
50 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 0 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
917 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:9772751:C:A | donor_gain | 1.0000 |
| 17:9772765:A:AC | donor_gain | 1.0000 |
| 17:9772766:C:CC | donor_gain | 1.0000 |
| 17:9772766:CATTT:C | donor_gain | 1.0000 |
| 17:9772784:T:TA | donor_gain | 1.0000 |
| 17:9772785:C:A | donor_gain | 1.0000 |
| 17:9773493:C:CT | acceptor_gain | 1.0000 |
| 17:9777191:A:AC | donor_gain | 1.0000 |
| 17:9777192:C:CC | donor_gain | 1.0000 |
| 17:9777192:CAAGT:C | donor_gain | 1.0000 |
| 17:9779818:A:AC | donor_gain | 1.0000 |
| 17:9779819:C:CC | donor_gain | 1.0000 |
| 17:9779819:CGAGA:C | donor_gain | 1.0000 |
| 17:9780045:C:CT | acceptor_gain | 1.0000 |
| 17:9780046:A:T | acceptor_gain | 1.0000 |
| 17:9791127:TTACC:T | donor_loss | 1.0000 |
| 17:9791129:A:AC | donor_gain | 1.0000 |
| 17:9791129:AC:A | donor_gain | 1.0000 |
| 17:9791129:ACCCT:A | donor_loss | 1.0000 |
| 17:9791130:C:CC | donor_gain | 1.0000 |
| 17:9791130:C:G | donor_loss | 1.0000 |
| 17:9791130:CC:C | donor_gain | 1.0000 |
| 17:9771692:AAAGA:A | acceptor_gain | 0.9900 |
| 17:9771693:AAGA:A | acceptor_gain | 0.9900 |
| 17:9771694:AGA:A | acceptor_gain | 0.9900 |
| 17:9772750:T:TA | donor_gain | 0.9900 |
| 17:9772761:TCTCA:T | donor_loss | 0.9900 |
| 17:9772762:CTCAC:C | donor_loss | 0.9900 |
| 17:9772763:TCA:T | donor_loss | 0.9900 |
| 17:9772764:CACAT:C | donor_loss | 0.9900 |
AlphaMissense
2031 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:9772913:G:A | S195F | 0.991 |
| 17:9772916:G:T | A194D | 0.991 |
| 17:9772913:G:T | S195Y | 0.990 |
| 17:9779935:A:G | L124P | 0.989 |
| 17:9791166:A:T | V40E | 0.987 |
| 17:9771567:C:G | R287P | 0.986 |
| 17:9772877:C:G | R207P | 0.985 |
| 17:9772880:A:G | L206P | 0.985 |
| 17:9772882:G:C | C205W | 0.985 |
| 17:9781592:A:G | C53R | 0.983 |
| 17:9791163:A:T | V41E | 0.983 |
| 17:9772891:G:C | F202L | 0.982 |
| 17:9772891:G:T | F202L | 0.982 |
| 17:9772893:A:G | F202L | 0.982 |
| 17:9772904:G:T | A198E | 0.982 |
| 17:9779941:T:A | D122V | 0.982 |
| 17:9772905:C:G | A198P | 0.980 |
| 17:9777279:A:G | L163P | 0.980 |
| 17:9772843:G:C | S218R | 0.978 |
| 17:9772843:G:T | S218R | 0.978 |
| 17:9772845:T:G | S218R | 0.978 |
| 17:9781588:G:T | A54D | 0.978 |
| 17:9781550:A:G | C67R | 0.977 |
| 17:9781555:A:T | V65E | 0.976 |
| 17:9771579:G:T | A283D | 0.975 |
| 17:9779853:A:C | N151K | 0.975 |
| 17:9779853:A:T | N151K | 0.975 |
| 17:9779845:C:T | G154D | 0.974 |
| 17:9772880:A:T | L206H | 0.973 |
| 17:9777243:A:T | V175E | 0.973 |
dbSNP variants (sampled 300 via entrez): RS1000113368 (17:9778195 T>C), RS1000272721 (17:9772586 G>A), RS1000311905 (17:9783159 T>C), RS1000371908 (17:9789049 G>A), RS1000557956 (17:9784735 T>C), RS1000708587 (17:9790097 A>C), RS1000901299 (17:9783242 C>G,T), RS1000950129 (17:9782683 C>T), RS1000963411 (17:9772548 C>A,T), RS1001037593 (17:9778043 A>G,T), RS1001052990 (17:9784494 CAG>C), RS1001099006 (17:9776905 C>T), RS1001109903 (17:9778400 A>G), RS1001304593 (17:9791272 C>T), RS1001356469 (17:9791600 T>C,G)
Disease associations
OMIM: gene MIM:616161 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aflatoxin B2 | decreases methylation | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Folic Acid | decreases expression | 1 |
| NADP | affects binding, increases activity | 1 |
| Rotenone | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.